ALX Oncology Holdings Inc. (ALXO) Misses Q3 EPS by 4c
Tweet
Share
E-mail
Get Alerts ALXO Hot Sheet
Join SI Premium – FREE
ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Full Circle Lithium closes $5.14M private placement
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
